Identification of potential diagnostic and prognostic biomarkers for breast cancer based on gene expression omnibus

Figure 5 Calreticulin, chromodomain helicase DNA binding protein 4, eukayotic translation elongation factor 1 alpha 1, epidermal growth factor receptor, heat shock protein family B member 1, insulin-like growth Factor 1, interleukin-1 receptor 1, Krüppel-like factor 4, mesencephalic astrocyte-derivedneurotrophic factor, pyruvate kinase M1/2, protein tyrosine phosphatase receptor type C, signal peptidase complex subunit gene 11 homolog C, suppressor of cytokine signaling 3, posphoinositide-3-kinase regulatory subunit 1, and triosephosphate isomerase 1 expression in breast cancer matched The Cancer Genome Atlas normal and GTEx data based on the GEPIA database. CALR: Calreticulin; CHD4: Chromodomain helicase DNA binding protein 4; EEF1A1: Eukayotic translation elongation factor 1 alpha 1; EGFR: Epidermal growth factor receptor; HSPB1: Heat shock protein family B member 1; IGF1: Insulin-like growth Factor 1; IL1R1: Interleukin-1 receptor 1; KLF4: Krüppel-like factor 4; MANF: Mesencephalic astrocyte-derivedneurotrophic factor; PKM: Pyruvate kinase M1/2; PTPRC: Protein tyrosine phosphatase receptor type C; SEC11C: Signal peptidase complex subunit gene 11 homolog C; SOCS3: Suppressor of cytokine signaling 3; PIK3R1: Posphoinositide-3-kinase regulatory subunit 1; TPI1: Triosephosphate isomerase 1.